Svas Biosana SpA (MIL:SVS) Other Stockholders Equity: €25.7 Mil (As of Dec. 2025)


MIL:SVS Svas Biosana SpA MIL:SVS
79 GF Score
Price €8.90
GF Value €9.64
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Svas Biosana SpA Other Stockholders Equity?

Svas Biosana SpA MIL:SVS +0.68% 79 Other Stockholders Equity is €25.7 Mil as of Dec. 2025. GuruFocus rates MIL:SVS with a GF Score™ of 79/100 and a GF Value™ of €9.64 (Fairly Valued). The stock has 3 warning signs investors should review.

Svas Biosana SpA's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €25.7 Mil.

Svas Biosana SpA's quarterly Other Stockholders Equity declined from Dec. 2024 (€26.0 Mil) to Jun. 2025 (€25.7 Mil) and declined from Jun. 2025 (€25.7 Mil) to Dec. 2025 (€25.7 Mil).

Svas Biosana SpA's annual Other Stockholders Equity declined from Dec. 2023 (€26.6 Mil) to Dec. 2024 (€26.0 Mil) and declined from Dec. 2024 (€26.0 Mil) to Dec. 2025 (€25.7 Mil).

Svas Biosana SpA Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Svas Biosana SpA's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Svas Biosana SpA Other Stockholders Equity Chart

Svas Biosana SpA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 24.44 26.01 26.61 25.98 25.72

Svas Biosana SpA Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.61 26.07 25.98 25.73 25.72
MIL:SVS
79GF Score
Svas Biosana SpA MIL:SVS
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Svas Biosana SpA Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €25.7 Mil mean?
Svas Biosana SpA (MIL:SVS) has a Other Stockholders Equity of €25.7 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Svas Biosana SpA and its competitors.
Is Svas Biosana SpA's Other Stockholders Equity too high?
Svas Biosana SpA's current Other Stockholders Equity is €25.7 Mil. Overall, Svas Biosana SpA has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Svas Biosana SpA's Other Stockholders Equity compare to ABT and SYK?
Svas Biosana SpA's Other Stockholders Equity of €25.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Svas Biosana SpA and its competitors. Svas Biosana SpA's current Other Stockholders Equity is €25.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Svas Biosana SpA stock overvalued right now?
Based on GuruFocus' analysis, Svas Biosana SpA (MIL:SVS) is currently considered Fairly Valued. The stock's GF Value™ is €9.64, compared to a current price of €8.90 — trading 7.7% below its estimated fair value. The current Other Stockholders Equity is €25.7 Mil. Svas Biosana SpA's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Svas Biosana SpA (MIL:SVS), the current Other Stockholders Equity is €25.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Svas Biosana SpA (MIL:SVS) Overvalued in 2026?

Based on GuruFocus' analysis, Svas Biosana SpA stock appears to be undervalued. The current stock price of €8.90 is trading 7.7% below its estimated GF Value™ of €9.64. GuruFocus considers Svas Biosana SpA to be Fairly Valued.

Key valuation signals for MIL:SVS:

  • Other Stockholders Equity: €25.7 Mil
  • GF Value™: €9.64 vs. price of €8.90 (7.7% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the MIL:SVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Svas Biosana SpA Business Description

Address Via Trentola, 7, Somma Vesuviana, ITA
Svas Biosana SpA operates in the production and distribution of medical device.
79GF Score

Get the complete analysis for MIL:SVS

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.90
Price
€9.64
GF Value